These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3384998)

  • 1. Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas.
    Henzen-Logmans SC; Schipper NW; Poels LG; Stolk K; Kenemans P; Meyer CJ
    J Clin Pathol; 1988 Jun; 41(6):644-9. PubMed ID: 3384998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
    Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
    Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
    Bar J; Sobańska E
    Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COTA (colon-ovarian tumor antigen). An immunohistochemical study.
    Pant KD; Fenoglio-Preiser CM; Berry CO; Zamora PO; Ram MD; Fulks RM; Rhodes BA
    Am J Clin Pathol; 1986 Jul; 86(1):1-9. PubMed ID: 3524190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of glycoprotein expression between ovarian and colon adenocarcinomas.
    Multhaupt HA; Arenas-Elliott CP; Warhol MJ
    Arch Pathol Lab Med; 1999 Oct; 123(10):909-16. PubMed ID: 10506443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of colon specific antigen and colon ovarian tumour antigen.
    Dorman AM; Chin D; Leader M
    J Clin Pathol; 1992 Oct; 45(10):932-3. PubMed ID: 1385484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic ovarian or colonic cancer: a clinical challenge.
    Taal BG; Hageman PC; Delemarre JF; Bonfrèr JM; den Hartog Jager FC
    Eur J Cancer; 1992; 28(2-3):394-9. PubMed ID: 1591052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a common antigen of colorectal and mucinous ovarian tumors, COTA.
    Pant KD; Zamora PO; Rhodes BA; Sachatello CR; Hagihara PF; Griffen WO; van Nagell JR; Fulks R; Ram MD
    Tumour Biol; 1984; 5(5):243-54. PubMed ID: 6442455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of colon-ovarian tumor antigen in adenocarcinomas. An immunohistochemical study of 501 cases.
    Loy TS; Darkow GV
    Am J Clin Pathol; 1993 Feb; 99(2):207-10. PubMed ID: 7679875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
    Pires Y; Andrade L; Cuello M; Chuaqui R
    Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
    Loy TS; Calaluce RD; Keeney GL
    Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a carbohydrate differentiation antigen, stage-specific embryonic antigen 1, in human colonic adenocarcinoma.
    Shi ZR; McIntyre LJ; Knowles BB; Solter D; Kim YS
    Cancer Res; 1984 Mar; 44(3):1142-7. PubMed ID: 6141004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.
    Edwards C; Oates J
    J Clin Pathol; 1995 Jul; 48(7):626-30. PubMed ID: 7560168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.
    Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H
    Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin-like carcinoma-associated antigen serum levels in patients with adenocarcinomas originating from ovary, breast and colon.
    Bon GG; Verheijen RH; Zuetenhorst JM; van Kamp GJ; Verstraeten AA; Kenemans P
    Gynecol Obstet Invest; 1996; 42(1):58-62. PubMed ID: 8840180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy.
    Younes M; Katikaneni PR; Lechago LV; Lechago J
    Mod Pathol; 1994 Apr; 7(3):396-400. PubMed ID: 8058715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
    Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
    Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.